India  

All-India vaccine rollout set for next week: Govt

IndiaTimes Tuesday, 5 January 2021 ()
The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian regulator granted the EUA on January 3. The drug regulator announced grant of restricted emergency use authorisation to two companiesPune-based Serum Institute of India for Covishield, the vaccine developed by Oxford University and Astra Zeneca, and Hyderabad-based Bharat Biotech that has developed Covaxin in collaboration with ICMR.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

India may get four more COVID-19 vaccines soon, SII says work in progress

According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
DNA
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

This dog arrived in elevator for a walk by a neighbor while the owner has COVID [Video]

This dog arrived in elevator for a walk by a neighbor while the owner has COVID

This woman unexpectedly became a dog walker for a stranger in her apartment building in Poland while the dog's owner is quarantining with COVID-19.

Credit: USA Today News (International)    Duration: 00:35Published
Coronavirus in numbers: UK death toll reaches 89,860 [Video]

Coronavirus in numbers: UK death toll reaches 89,860

Public Health England said a further 599 people had died within 28 days oftesting positive for Covid-19 in the UK as of Monday.

Credit: PA - Press Association STUDIO    Duration: 00:37Published

COVID-19: Two dead after receiving shot, govt says deaths not linked to vaccine

Since the beginning of the COVID-19 vaccination drive in India on January 16, 580 adverse events were observed and seven people were hospitalised.
DNA

England in Six Nations: Jason Ryles absent because of Covid-19 travel fears

Assistant coach Jason Ryles will not be with England for the Six Nations because of travel concerns but hopes to re-join the staff for the summer fixtures.
BBC Sport
580 adverse events reported post-COVID immunisation: Health Ministry [Video]

580 adverse events reported post-COVID immunisation: Health Ministry

Additional Secretary of Health Ministry Manohar Agnani informed that a total of 580 adverse events were reported post-vaccination drive. He said, "A cumulative of 580 Adverse Events Following Immunisation (AEFIs) has been reported. Of which 7 have been hospitalised."

Credit: ANI    Duration: 01:03Published

Emergency Use Authorization

U.S. FDA authorizes second COVID-19 vaccine [Video]

U.S. FDA authorizes second COVID-19 vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

Credit: Reuters - Politics    Duration: 00:45Published
U.S. FDA authorizes second vaccine [Video]

U.S. FDA authorizes second vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

Credit: Reuters - Politics    Duration: 00:45Published
2nd COVID-19 vaccine set for OK in US with FDA panel endorsement [Video]

2nd COVID-19 vaccine set for OK in US with FDA panel endorsement

The FDA's Vaccines and Related Biological Products Advisory Committee has recommended the Emergency Use Authorization (EUA) to a COVID-19 vaccine made by Moderna.

Credit: ABC Action News    Duration: 02:04Published
FDA to vote on EUA for Pfizer's COVID-19 vaccine [Video]

FDA to vote on EUA for Pfizer's COVID-19 vaccine

19 vaccine candidate items.[0].image.alt A generic image of a needle and medication. By: Justin BoggsPosted at 7:09 PM, Dec 09, 2020 and last updated 1:19 PM, Dec 10, 2020 The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee is currently holding a meeting to consider Pfizer’s coronavirus vaccine, which has already gotten authorization from officials in Canada and the UK.

Credit: ABC Action News    Duration: 02:00Published
Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine [Video]

Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine

Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.

Credit: ABC Action News    Duration: 01:51Published

AstraZeneca British-Swedish pharmaceutical company

Vaccine manufacturing is lumpy, UK says [Video]

Vaccine manufacturing is lumpy, UK says

Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:24Published
Sao Paulo nurse first to get CoronaVac shot in Brazil [Video]

Sao Paulo nurse first to get CoronaVac shot in Brazil

Monica Calazans, a 54-year-old nurse in Sao Paulo, became on Sunday the first person to be inoculated in Brazil, receiving the Chinese vaccine known as CoronaVac after Brazilian health regulator Anvisa approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca.

Credit: Reuters Studio    Duration: 00:54Published
Easing of lockdown restrictions not before March, says Zahawi [Video]

Easing of lockdown restrictions not before March, says Zahawi

Vaccines minister Nadhim Zahawi has suggested that a gradual easing oflockdown restrictions will not begin before early March. He told BBCBreakfast: “If we take the mid-February target, two weeks after that you getyour protection, pretty much, for the Pfizer/BioNTech, three weeks for theOxford/AstraZeneca, you are protected. “One of the things we don’t know yet,and the deputy chief medical officer Jonathan Van-Tam is on record as saying‘look give me a couple of months and I’ll tell you’, is the impact of thevaccine on transmission rates ie on infecting people. “So there are a numberof caveats that stand in the way of us reopening the economy. “It will begradually, it will be probably through the tiered system but you’re looking atthat sort of period, two to three weeks after the middle of February, afterwe’ve protected the top four cohorts.”

Credit: PA - Press Association STUDIO    Duration: 00:53Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

Serum Institute expects WHO emergency approval for AstraZeneca shot soon

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for..
IndiaTimes

University of Oxford University of Oxford Collegiate research university in Oxford, England

COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab [Video]

COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab

The pace of the UK's vaccine rollout was ramped up this week with the opening of seven new mass vaccination centres

Credit: Euronews English    Duration: 02:33Published

AstraZeneca 'on track' to deliver two million doses a week - as it calls for priority access

AstraZeneca says it expects to release two million doses of the Oxford vaccine every week by mid-February - and has asked for its workers to get priority access..
Sky News
Study: Ireland saw highest global coronavirus infection rate [Video]

Study: Ireland saw highest global coronavirus infection rate

New research from Oxford University shows Ireland had the highest coronavirus infection rate globally in the seven days leading up to January 10, 2021. CNN’s Nic Robertson reports.

Credit: Bleacher Report AOL    Duration: 01:58Published

Hyderabad Hyderabad Capital of Telangana, India

Vaccines approved only after testing: G Kishan Reddy confident of efficacy [Video]

Vaccines approved only after testing: G Kishan Reddy confident of efficacy

Minister of State for Home Affairs G Kishan Reddy inaugurated vaccination drive at Gandhi Hospital in Hyderabad on January 16. On the rumours around the efficacy of the vaccine, G Kishan Reddy said that medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. He further assured that vaccines have been approved only after testing."I request people to not say such things. Medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. I request not to discuss things like this. Vaccines have been approved only after testing. I say this confidently that the vaccines will benefit everyone," said MoS Home Affairs G Kishan Reddy.

Credit: ANI    Duration: 01:11Published
COVID-19 vaccination drive begins in India [Video]

COVID-19 vaccination drive begins in India

The mega COVID-19 vaccination drive began in India on January 16. Prime Minister Narendra Modi launched the drive and around 100 healthcare workers will get vaccinated at each session site on the inaugural day. Manish Kumar, a sanitation worker, became the first person to receive COVID-19 vaccine jab at AIIMS. In the first phase of COVID-19 vaccination drive, healthcare workers will receive the vaccine. The beneficiaries reached to their respective health centres. Two COVID vaccines have been approved in India- Pune-based SII's 'Covishield' and Hyderabad-based Bharat Biotech's 'Covaxin'.

Credit: ANI    Duration: 01:41Published
Mega COVID vaccination drive to begin in India today [Video]

Mega COVID vaccination drive to begin in India today

The mega COVID-19 vaccination drive will begin in India on January 16. The preparations are underway at health centres across the country. Hyderabad's Nampally area hospital is all decked up to begin the drive today. Prime Minister Narendra Modi will launch the vaccination drive today via video-conferencing.

Credit: ANI    Duration: 01:26Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Indian Council of Medical Research Indian Council of Medical Research

India records 13,788 new COVID cases in last 24 hours [Video]

India records 13,788 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 18 reported single-day spike of 13,788 new coronavirus cases in the last 24 hours. 145 deaths in the same period pushed the COVID-19 toll in the country to 1,52,419. India's confirmed cases of coronavirus stand at 1,05,71,773 which include 2,08,012 active infections. More than 1,02,11,342 people have recovered from the virus with 14,457 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 5,48,168 samples were tested on January 17. Cumulative samples tested for COVID-19 till January 17 are 18,70,93,036.

Credit: ANI    Duration: 01:26Published
COVID-19: Total cases cross 1.05 crore-mark in India [Video]

COVID-19: Total cases cross 1.05 crore-mark in India

On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges, total number reached to 1,01,79715. 175 deaths were reported in last 24 hours, taking cumulative toll to 1,52,093. According to ICMR, total number of samples tested up to 11th January is 18,57,65,491 and of these, 8,03,090 samples were tested yesterday.

Credit: ANI    Duration: 01:52Published
COVID-19: Active cases in India dip to 2,10,l06 [Video]

COVID-19: Active cases in India dip to 2,10,l06

On January 15, India reported 15,677 new COVID-19 cases and 189 deaths in last 24 hours. The active cases stands at 2,10,l06. With new 15,848 discharges, total number reached to 1,01,62,082. 189 deaths were reported in last 24 hours, taking cumulative toll to 1,51,954. According to ICMR, total number of samples tested up to 14th January is 18,49,62,401 and of these, 7,30,096 samples were tested yesterday.

Credit: ANI    Duration: 01:45Published

Related videos from verified sources

Governor calling on government to give New York more vaccines [Video]

Governor calling on government to give New York more vaccines

Governor Andrew Cuomo is calling on the federal government to step up its vaccine distribution. This comes as New York is set to receive 250,000 doses of the coronavirus vaccine next week. The governor..

Credit: WKTVPublished
Vaccines for seniors: Agencies provide info for next phase targeting those over 80 [Video]

Vaccines for seniors: Agencies provide info for next phase targeting those over 80

Health officials and providers in Summit County are gearing up for Phase 1B of the COVID-19 vaccine, which rolls out next week and targets people 80 years and older.

Credit: WEWS NewsChannel5     Duration: 02:41Published
Don't make mistake of ignoring 2nd dose of COVID-19 vaccine: PM Modi [Video]

Don't make mistake of ignoring 2nd dose of COVID-19 vaccine: PM Modi

Prime Minister Narendra Modi on January 16 reminded the people of India that the two doses of corona vaccine are very important. He said, "I want to remind people of the country that two doses of the..

Credit: ANI     Duration: 01:38Published